Cansino Biologics Stock Analysis

CanSino Pink Sheet Analysis Notes

About 27.0% of the company shares are held by company insiders. The book value of CanSino Biologics was currently reported as 29.22. The company last dividend was issued on the 13th of July 2022. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the Peoples Republic of China. Cansino Biologics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2191 people.The quote for CanSino Biologics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CanSino Biologics please contact the company at 400 922 2099 or go to https://www.cansinotech.com.

CanSino Biologics Investment Alerts

CanSino Biologics Thematic Classifications

CanSino Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CanSino Biologics's market, we take the total number of its shares issued and multiply it by CanSino Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

CanSino Profitablity

The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.

Technical Drivers

As of the 15th of March 2025, CanSino Biologics shows the Risk Adjusted Performance of 0.0815, downside deviation of 6.14, and Mean Deviation of 2.11. CanSino Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CanSino Biologics maximum drawdown, and the relationship between the information ratio and downside variance to decide if CanSino Biologics is priced correctly, providing market reflects its regular price of 4.72 per share. Given that CanSino Biologics has jensen alpha of 0.5053, we suggest you to validate CanSino Biologics's prevailing market performance to make sure the company can sustain itself at a future point.

CanSino Biologics Price Movement Analysis

CanSino Biologics Predictive Daily Indicators

CanSino Biologics Forecast Models

CanSino Biologics' time-series forecasting models are one of many CanSino Biologics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CanSino Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CanSino Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CanSino shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CanSino Biologics. By using and applying CanSino Pink Sheet analysis, traders can create a robust methodology for identifying CanSino entry and exit points for their positions.

When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.